SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : dsco Discovery Laboratories
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alex Glavinos who wrote (16)5/10/1999 2:46:00 PM
From: FFNEODOC   of 318
 
Good news... The lavage treatment for ARDS is an extension of the work that looks extremely promising to treat MAS in babies.
Expect this good news will continue, but the big payday for this stock, we all know, is contingent on FDA approval for Surfaxin for one of the multiple clinical trials. I still think the most likely first FDA indication will be the MAS in babies trial, since this is already in phase 3 & on the FDA fast track.
Frank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News